Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Givaudan Q1 sales

This article was originally published in The Rose Sheet

Executive Summary

Fine fragrance sales showed signs of recovery with double-digit local currency growth in the first quarter on "successful introduction of new business," Geneva, Switzerland fragrance and flavors supplier reports in April 11 1sales release. Consumer Products business began third consecutive year of positive growth with sales increasing high single digits in local currencies. Fragrance division sales, however, fell 2.6% to $203.9 mil. in Swiss Francs (CHF1=$.72). Fragrance ingredients business unit experienced "marginal" growth in the quarter. Declining sales in the segment are anticipated in the coming months due to the phase out of sunscreen filters, Givaudan says. Consolidated net sales for the first quarter increased 7.9% to $492.6 mil...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011140

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel